Answers are grounded in this paper and cite their sources.
Insights from drug utilization research enhance safe medication practices for children and adolescents, suggesting a need for better integration.
Despite their value, pediatric DUS remain underused in clinical and regulatory decision-making. DUS should be systematically integrated into the development and revision of clinical guidelines on medication use and used routinely to evaluate the effects of major regulatory initiatives. Establishing near - real-time monitoring systems and extending DUS to inpatient settings would further strengthen their ability to impact clinical practice and support safer and more evidence-based prescribing for children and adolescents.
No takes yet. Share an insight, caveat, or question.
Kildegaard et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: